ProRx LLC: Drug Recall
Recall #D-0656-2024 · 08/22/2024
Class II: Risk
Recall Details
- Recall Number
- D-0656-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ProRx LLC
- Status
- Ongoing
- Date Initiated
- 08/22/2024
- Location
- Exton, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,732 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
Distribution Pattern
Nationwide in the USA
Other Recalls by ProRx LLC
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.